BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24754677)

  • 1. Identification of type II and III DDR2 inhibitors.
    Richters A; Nguyen HD; Phan T; Simard JR; Grütter C; Engel J; Rauh D
    J Med Chem; 2014 May; 57(10):4252-62. PubMed ID: 24754677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
    Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
    J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
    Li Y; Lu X; Ren X; Ding K
    J Med Chem; 2015 Apr; 58(8):3287-301. PubMed ID: 25569119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
    Leitinger B
    J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2-mediated cancer progression.
    Kim D; Ko P; You E; Rhee S
    Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.
    Xu H; Raynal N; Stathopoulos S; Myllyharju J; Farndale RW; Leitinger B
    Matrix Biol; 2011 Jan; 30(1):16-26. PubMed ID: 21044884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
    Leitinger B; Steplewski A; Fertala A
    J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discoidin domain receptor DDR2 is a receptor for type X collagen.
    Leitinger B; Kwan AP
    Matrix Biol; 2006 Aug; 25(6):355-64. PubMed ID: 16806867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1.
    Mihai C; Iscru DF; Druhan LJ; Elton TS; Agarwal G
    J Mol Biol; 2006 Sep; 361(5):864-76. PubMed ID: 16884738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
    Abdulhussein R; McFadden C; Fuentes-Prior P; Vogel WF
    J Biol Chem; 2004 Jul; 279(30):31462-70. PubMed ID: 15136580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the collagen-binding mode of discoidin domain receptor 2.
    Ichikawa O; Osawa M; Nishida N; Goshima N; Nomura N; Shimada I
    EMBO J; 2007 Sep; 26(18):4168-76. PubMed ID: 17703188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of discoidin domain receptor 2 (DDR2) extracellular domain in pichia pastoris and functional analysis in synovial fibroblasts and NIT3T3 cells.
    Zhang W; Ding T; Zhang J; Su J; Li F; Liu X; Ma W; Yao L
    Mol Cell Biochem; 2006 Oct; 290(1-2):43-53. PubMed ID: 16967187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
    Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
    Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion expression of DDR2 extracellular domain in insect cells and its purification and function characterization.
    Zhang W; Ding T; Zhang J; Su J; Yu J; Li J; Li F; Wang C; Liu N; Liu X; Ma W; Yao L
    J Cell Biochem; 2007 Sep; 102(1):41-51. PubMed ID: 17427955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discoidin domain receptors: structural relations and functional implications.
    Vogel W
    FASEB J; 1999; 13 Suppl():S77-82. PubMed ID: 10352148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
    Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
    Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discoidin domain receptor tyrosine kinases: new players in cancer progression.
    Valiathan RR; Marco M; Leitinger B; Kleer CG; Fridman R
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):295-321. PubMed ID: 22366781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2.
    Flynn LA; Blissett AR; Calomeni EP; Agarwal G
    J Mol Biol; 2010 Jan; 395(3):533-43. PubMed ID: 19900459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen recognition and transmembrane signalling by discoidin domain receptors.
    Carafoli F; Hohenester E
    Biochim Biophys Acta; 2013 Oct; 1834(10):2187-94. PubMed ID: 23128141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
    Trono P; Ottavi F; Rosano' L
    Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.